We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $113B
1-Year Est. Return 38.87%
This Fund
S&P 500
This Quarter Est. Return
-14.15%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$69.6B
AUM Growth
-$16.5B
Cap. Flow
-$3.3B
Cap. Flow %
-4.75%
Top 10 Hldgs %
17.71%
Holding
779
New
83
Increased
294
Reduced
313
Closed
76
Avg Time Held
10.9 quarters
Top 10 Avg Time Held
7.5 quarters
Top 20 Avg Time Held
7.4 quarters

Top Sells

Rank Stock Value
1
ANDV
Andeavor
ANDV
+$1.05B
2
MRK icon
Merck
MRK
+$702M
3
BAC icon
Bank of America
BAC
+$542M
4
ORCL icon
Oracle
ORCL
+$528M
5
STLD icon
Steel Dynamics
STLD
+$499M

Sector Composition

Rank Sector Weight
1 Financials 26.74%
2 Healthcare 14.95%
3 Industrials 13.38%
4 Technology 12.24%
5 Energy 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NVS icon
26
Novartis
NVS
$273B
$605M 0.87%
7,864,222
+1,629,187
+26% +$127M
2013 Q4
20 quarters
MCK icon
27
McKesson
MCK
$111B
$591M 0.85%
5,349,038
-684,812
-11% -$85.4M
2013 Q2
22 quarters
HBAN icon
28
Huntington Bancshares
HBAN
$31B
$589M 0.85%
49,450,631
+17,411,546
+54% +$242M
2013 Q2
22 quarters
AIG icon
29
American International
AIG
$40.5B
$586M 0.84%
14,867,095
+1,797,115
+14% +$78.5M
2013 Q2
22 quarters
ORCL icon
30
Oracle
ORCL
$421B
$563M 0.81%
12,461,499
-11,022,414
-47% -$528M
2013 Q2
22 quarters
Y
31
DELISTED
Alleghany Corp
Y
$562M 0.81%
902,201
+13,861
+2% +$8.54M
2013 Q2
22 quarters
DAL icon
32
Delta Air Lines
DAL
$53.3B
$552M 0.79%
11,061,116
-2,266,748
-17% -$123M
2014 Q2
18 quarters
RDS.A
33
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$541M 0.78%
9,283,911
-332,260
-3% -$20.6M
2017 Q3
5 quarters
EG icon
34
Everest Group
EG
$14.3B
$535M 0.77%
2,456,873
+79,444
+3% +$17.3M
2017 Q4
4 quarters
TEL icon
35
TE Connectivity
TEL
$62.4B
$532M 0.77%
7,039,632
-3,182,117
-31% -$245M
2013 Q2
22 quarters
AON icon
36
Aon
AON
$58.2B
$528M 0.76%
3,634,161
+907,862
+33% +$141M
2014 Q4
16 quarters
DXC icon
37
DXC Technology
DXC
$2B
$511M 0.73%
9,618,304
-4,246,898
-31% -$293M
2017 Q2
6 quarters
GILD icon
38
Gilead Sciences
GILD
$187B
$502M 0.72%
8,018,715
-360,174
-4% -$25.2M
2014 Q4
16 quarters
ETN icon
39
Eaton
ETN
$167B
$501M 0.72%
7,290,529
-329,382
-4% -$24.6M
2015 Q1
15 quarters
SLG icon
40
SL Green Realty
SLG
$3.37B
$500M 0.72%
6,525,890
+773,987
+13% +$68.5M
2013 Q3
21 quarters
CMI icon
41
Cummins
CMI
$72.3B
$488M 0.7%
3,654,138
-1,737,404
-32% -$245M
2017 Q3
5 quarters
CCEP icon
42
Coca-Cola Europacific Partners
CCEP
$45.9B
$481M 0.69%
10,500,329
-95,046
-0.9% -$4.4M
2013 Q2
22 quarters
VMRK icon
43
Vivmark Residential
VMRK
$46.8B
$427M 0.61%
6,475,134
-57,488
-0.9% -$3.86M
2013 Q2
22 quarters
FMC icon
44
FMC
FMC
$1.28B
$427M 0.61%
6,651,958
+1,930,108
+41% +$135M
2017 Q2
6 quarters
NTR icon
45
Nutrien
NTR
$32.2B
$424M 0.61%
9,028,316
+155,876
+2% +$8.13M
2018 Q1
3 quarters
DOV icon
46
Dover
DOV
$25.5B
$420M 0.6%
5,913,428
+225,478
+4% +$18.4M
2018 Q1
3 quarters
COP icon
47
ConocoPhillips
COP
$165B
$419M 0.6%
6,727,301
-1,638,147
-20% -$111M
2016 Q3
9 quarters
MOS icon
48
The Mosaic Company
MOS
$5.92B
$416M 0.6%
14,243,641
+4,814,199
+51% +$158M
2015 Q1
15 quarters
LH icon
49
Labcorp
LH
$25.5B
$413M 0.59%
3,805,428
-1,391,918
-27% -$186M
2013 Q2
22 quarters
LUV icon
50
Southwest Airlines
LUV
$20.2B
$408M 0.59%
8,779,389
-230,436
-3% -$12.2M
2017 Q2
6 quarters

Similar funds

Boston Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Boston Partners held 779 positions worth $69.6B, down 19% from $86.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Partners withdrew a net $3.3B in Q4 2018, closing 76 positions and reducing 313 holdings. Its most notable exit was Andeavor, an estimated $1.05B position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Boston Partners opened a new position in Procter & Gamble worth $775M.

  • Boston Partners's largest Q4 2018 buy was Procter & Gamble: 8,428,522 shares worth $775M.
  • Boston Partners added most to Marathon Petroleum in Q4 2018, an estimated $374M increase.
  • Boston Partners's biggest Q4 2018 reduction was Merck, cutting an estimated $702M.
  • Boston Partners fully exited Andeavor in Q4 2018, selling an estimated $1.05B.
  • Boston Partners's ten largest holdings make up 18% of its $69.6B portfolio in Q4 2018.
  • Boston Partners opened 83 new positions and closed 76 in Q4 2018.
  • Boston Partners's portfolio value fell 19% quarter-over-quarter to $69.6B.

Based on Boston Partners's 13F filing for Q4 2018, filed 7 Feb 2019.